Compare RXO & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXO | PGNY |
|---|---|---|
| Founded | 2022 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Misc Health and Biotechnology Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | N/A | 2019 |
| Metric | RXO | PGNY |
|---|---|---|
| Price | $14.61 | $24.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 10 |
| Target Price | $15.77 | ★ $27.90 |
| AVG Volume (30 Days) | ★ 2.0M | 1.4M |
| Earning Date | 02-06-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.96 |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $5,940,000,000.00 | $1,268,689,000.00 |
| Revenue This Year | $27.80 | $11.63 |
| Revenue Next Year | $3.01 | $9.52 |
| P/E Ratio | ★ N/A | $40.24 |
| Revenue Growth | ★ 53.85 | 11.41 |
| 52 Week Low | $10.43 | $17.98 |
| 52 Week High | $26.92 | $28.75 |
| Indicator | RXO | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 42.38 |
| Support Level | $14.35 | $24.62 |
| Resistance Level | $16.26 | $25.45 |
| Average True Range (ATR) | 0.73 | 1.18 |
| MACD | 0.03 | -0.25 |
| Stochastic Oscillator | 43.09 | 6.36 |
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.